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ABSTRACT
The Cockayne syndrome B (CSB) protein—defective
in a majority of patients suffering from the
rare autosomal disorder CS—is a member of the
SWI2/SNF2 family with roles in DNA repair and
transcription. We demonstrate herein that purified
recombinant CSB and the major human apurinic/
apyrimidinic (AP) endonuclease, APE1, physically
and functionally interact. CSB stimulates the AP
site incision activity of APE1 on normal (i.e. fully
paired) and bubble AP–DNA substrates, with the
latter being more pronounced (up to 6-fold). This
activation is ATP-independent, and specific for
the human CSB and full-length APE1 protein, as no
CSB-dependent stimulation was observed with
Escherichia coli endonuclease IV or an N-terminal
truncated APE1 fragment. CSB and APE1 were
also found in a common protein complex in
human cell extracts, and recombinant CSB, when
added back to CSB-deficient whole cell extracts,
resulted in increased total AP site incision capacity.
Moreover, human fibroblasts defective in CSB were
found to be hypersensitive to both methyl meth-
anesulfonate (MMS) and 5-hydroxymethyl-
20-deoxyuridine, agents that introduce base excision
repair (BER) DNA substrates/intermediates.
INTRODUCTION
Cockayne syndrome (CS) is a rare autosomal recessive
genetic disorder, classified as a segmental premature-aging
syndrome (1–3). The clinical features of this disease
include poor growth (‘cachectic dwarfism’), neurological
abnormalities and cutaneous photosensitivity. However,
in contrast to xeroderma pigmentosum (XP) patients—
who also exhibit increased sensitivity to ultraviolet (UV)
irradiation—individuals with CS do not display elevated
cancer risk. CS is divided into two complementation
groups: CSA (mutation in CKN1) and CSB (mutation in
ERCC6). Of the patients suffering from CS, 80% have
mutations in the CSB gene (1).
The CSB protein is composed of 1493 amino acids, and
based on sequence homology, has been placed into the
SWI2/SNF2 family of proteins that harbor seven helicase-
like ATPase motifs (4,5). Although no helicase activity
has been ascribed to CSB (6,7), the protein possesses a
DNA-dependent ATPase activity (6–8). Moreover, since
purified CSB (i) promotes alterations in the DNA
conformation upon binding to the double-helix and
(ii) alters the arrangement of nucleosome complexes
(at the expense of ATP hydrolysis), the protein has been
suggested to function as a chromatin remodeling factor
(9). This function appears dependent on the ability of
the protein to wrap and unwrap DNA molecules (10).
More recently, CSB was found to possess homologous
DNA strand pairing activity (11).
Numerous studies indicate that CSB participates
in transcription-coupled nucleotide excision repair
(TC-NER), as well as in global genome DNA repair
and general transcription (1,12). In particular, CSB
mutant cells exhibit hypersensitivity to a number
of DNA-damaging agents, including UV light (4),
4-nitroquinoline-1-oxide (4-NQO) (13), and N-acetoxy-
2-acetylaminofluorene (NA-AAF) (14,15). In the case of
UV, the hypersensitivity has been attributed to a specific
defect in the ability of CSB mutant cells to repair
DNA damage within actively transcribed genes (16,17).
A link of CSB to TC-NER is supported by the
observations that (i) CSB-defective cells are unable to
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recover RNA synthesis following DNA-damaging agent
treatment (4) and (ii) CSB binds RNA polymerase II when
arrested at a template lesion in vitro and promotes
recruitment of TFIIH, a factor involved in transcription
and NER (18–20). Results also indicate that CSB plays
a more general role in DNA repair, promoting
changes in the chromatin structure to facilitate damage
processing, particularly within active genes (21), and
assists RNA polymerase I- or II-directed transcription
(18,22–25).
Accumulating evidence suggests a role for CSB in base
excision repair (BER) (1). BER is responsible for
correcting most spontaneous, oxidative, or alkylation
forms of DNA base or sugar damage. The observation
that CSB/ cells, at least certain cell types, display
hypersensitivity to agents that generate reactive oxygen
species (ROS), such as IR, paraquat and hydrogen
peroxide, supports a role for the encoded protein in the
repair of oxidative lesions (26–28). Moreover, biochemical
assays using extracts from mutant cells indicate that CSB
is responsible for promoting incision at 8-oxo-dG, a
frequent oxidative base lesion and a marker of oxidative
damage (26,29). In fact, global genome as well as
mitochondrial DNA repair of 8-oxo-dG requires a
functional CSB gene product in vivo (30–32). CSB
mutant cells also exhibit a defect in the global repair of
8-hydroxyadenine, another oxidative base modification
(33). Work from Flohr et al. (34) suggests that the efficient
repair of oxidative base lesions through poly(ADP-ribose)
polymerase 1 (PARP-1), a key DNA damage response
protein, is likewise dependent on CSB. In addition,
Thorslund et al. (35) identified a physical and functional
interaction between CSB and PARP-1, and reported
that poly(ADP)-ribosylation of CSB inhibits its DNA-
dependent ATPase activity. Spivak et al. (36) have shown
that reactivation of a plasmid containing a thymine
glycol is defective in CSB mutant cells, further support-
ing a role for this protein in oxidative DNA damage
repair. Although evidence exists for a function of CSB
specifically in TC-BER, such a role has recently become
unclear (37). It has been postulated that a defect in gene-
specific and/or global genome repair of endogenous DNA
damage gives rise to the premature-aging symptoms and
increased neurological deficiencies associated with CS
patients (38).
In mammalian cells, APE1 is the major apurinic/
apyrimidinic (AP) endonuclease, operating to initiate
repair of mutagenic and cytotoxic AP sites by incising
the DNA backbone immediately adjacent to the lesion
(39). AP sites are formed by spontaneous base loss
(at a frequency of 10 000 events per mammalian
genome per day), as well as by increased base release
due to chemical modification (e.g. alkylation or oxidation)
or through the action of DNA repair glycosylases that
excise specific base damages. Following APE1 incision,
subsequent participants of the BER pathway remove the
50-terminal abasic fragment, replace the damaged nucleo-
tide and seal the final nick to restore genome integrity. We
describe herein data indicating a role for CSB in the repair
of BER substrates/intermediates, and a specific functional
interaction of CSB with the predominant AP site repair
enzyme, APE1.
MATERIALS AND METHODS
Dot-blot interaction screen
The DiscoverLight Protein Array Kit (Pierce, Rockford,
IL, USA) was used to screen for interactions between
purified CSB and select proteins. As described elsewhere
(40,41), various protein amounts were spotted on the
membranes, which were then dried and blocked in PBS-T
(1PBS, 0.1% Tween 20) containing 5% bovine serum
albumin (BSA) for 1 h at room temperature. The
membranes were then incubated with CSB (10 ng/ml) for
1 h at room temperature. A duplicate membrane was
incubated with blocking buffer alone as a control for
possible cross-reactivity with the CSB antibody. After
washing with PBS-T, the membranes were probed with
monoclonal mouse anti-CSB antibody (1 : 2000, kindly
provided by Dr Jean Marc-Egly, Institut de Ge´ne´tique
et de Biologie Mole´culaire et Cellulaire) overnight.
After washing, the membranes were incubated with
secondary antibody (1 : 10 000, anti-mouse IgG-horse-
radish peroxidase (HRP); Vector, Burlingame, CA, USA)
for 1 h at room temperature, washed again and then
developed with the SuperSignal West Pico chemilumines-
cent kit (Pierce).
Direct and indirect ELISA
Full-length, recombinant CSB and APE1 proteins were
expressed and purified as previously detailed (8,42).
Enzyme-linked immunosorbent assays (ELISAs) were
performed essentially as described (43). Briefly, in the
direct ELISAs, either BSA or APE1 (30 fmol) was coated
onto a 96-well plate and then incubated with increasing
amounts of CSB for 2 h at 378C. After several washes,
bound CSB was detected with anti-CSB antibody,
followed by HRP-conjugated secondary antibody. For
the indirect ELISA, either CSB (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) or APE1
(Trevigen, Gaithersburg, MD, USA) polyclonal antibody
was coated overnight at 48C on a 96-well plate, and then
incubated with either CSB (6 fmol=1ng) or APE1
(30 fmol=1ng) protein, respectively. After incubation
with increasing amounts of the partner protein
(i.e. APE1 or CSB) for 2 h at 378C, bound protein was
detected with either CSB or APE1 (Trevigen) mono-
clonal antibodies, followed by the secondary antibody
steps described above. Where indicated, ethidium bro-
mide (Invitrogen, Carlsbad, CA, USA) or DNase I
(Sigma–Aldrich, St Louis, MO, USA) was added at
10 mg/ml or 5 mg/ml, respectively. The protein interaction
was detected using OPD substrate (Sigma–Aldrich).
Reactions were terminated after 3min incubation with
3N H2SO4 and plates were read at 490 nm using a
Bio-Rad Benchmark Plus microplate spectrophotometer
and Microplate Manager 5.2 software (Bio-Rad
Laboratories, Hercules, CA, USA).
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Immunoprecipitation
ECFP-CSB-CS1AN cells, which were created as described
(8), were lysed in radioimmunoprecipitation assay (RIPA)
buffer [50mM Tris–HCl (pH 7.4), 1% NP-40, 0.25%
Na-deoxycholate, 150mM NaCl, 1mM EDTA, 1mM
phenylmethylsulfonyl fluoride, 1mM Na3VO4, 1mM
NaF, 10U/ml DNase I and 1 tablet Complete protease
inhibitor cocktail (Roche, Basel, Switzerland) per 50ml]
by sonication. After cell disruption, the suspension was
centrifuged at 14 000 g for 15min. The supernatant
represented the whole cell extract, and the protein
concentration was determined using the Bio-Rad Protein
Assay (Bio-Rad Laboratories). For immunoprecipitation,
ECFP–CSB whole cell extracts were pre-cleared with
Protein G-Agarose beads (Invitrogen). The pre-cleared
extracts (4mg each) were then immunoprecipitated with
either negative control rabbit IgG antibody (Santa Cruz
Biotechnology), living colors full-length A.v. (i.e. anti-
ECFP; 1 : 100) polyclonal rabbit antibody (BD bio-
sciences, San Jose, CA, USA), or mouse monoclonal
APE1 antibody (Novus, Littleton, CO; 1 : 50) for over-
night at 48C. Samples were next incubated with Protein G-
Agarose beads (30 ml) at 48C for 1 h, followed by multiple
washes. Bound proteins were eluted by boiling in SDS
sample buffer and were analyzed by SDS-PAGE and
western blotting using mouse anti-CSB (1 : 1000; Dr Egly),
or mouse anti-APE1 (1 : 1000; Novus) antibodies, fol-
lowed by chemiluminescent analysis (Pierce).
AP endonuclease assay
The AP site-containing (i.e. the tetrahydrofuran, F,
analog) 42-mer oligonucleotides used were: CCGCT
GAATTGCACCCTCGAFCTAGGTCGATGATCCTA
AGCA (42F-11), TGCTTAGGATCATCGACCTAGG
TCGAGGGTGCAATTCAGCGG (42F comp) and TG
CTTAGGATCATCGAGGATCGAGCTCGGTGCAAT
TCAGCGG (42F bubble comp). Following the genera-
tion of normal (42F-11:42 comp) or bubble (42F-11:42F
bubble comp) 32P-end labeled duplex substrates, incision
assays were performed at 378C for 10min with APE1
(10 or 30 fmol) and analyzed on denaturing polyacryla-
mide gels as previously described (44). Reactions consisted
of 50mM HEPES-KOH, pH 7.4, 50mM KCl, 5%
glycerol, 10mM MgCl2, 100 mg/ml BSA, 0.05% Triton
X-100 and 200 fmol of DNA. Where indicated, increasing
amounts of CSB were added. Escherichia coli endonu-
clease IV and truncated 29APE1 were purified as
described (42). Whole cell extract total AP endonuclease
activity was determined for CSB-V and CSB-WT cells
according to previously published methods (45).
Immunodepleted CSB supernatant fractions were
obtained according to the procedure of (8). In brief,
15 mg of recombinant HA/His-tagged CSB was mixed with
protein A magnetic beads (New England Biolabs, Ipswich,
MA, USA) that had been pre-incubated with rabbit
polyclonal anti-HA antibody (Santa Cruz Biotechnology).
After an overnight incubation, the supernatant was
separated from the beads by centrifugation, and kept as
the immunodepleted fraction (ID CSB). Beads were
washed and CSB was eluted with 0.5mg/ml of HA
peptide in buffer A (8) containing 0.5M KCl to generate
the immunoprecipitated (or immunopurified) CSB protein
(IP CSB).
AP site measurements
The number of AP sites in isolated chromosomal
DNA was determined using an aldehyde reactive
probe reagent (N0-aminooxymethyl-carbonyl-hydrazino-
D-biotin) and the DNA damage quantification kit of
Dojindo Molecular Technology (Gaithersburg, MD,
USA) as described (46).
Cellular sensitivity assays
CS1AN.S3.G2 SV40-transformed human skin fibroblast
cell lines (4,47)—stably transfected with either the
mammalian expression vector pcDNA3.1 (CSB-V),
pcDNA3.1 containing the wild-type human CSB gene
(CSB-WT), or pcDNA3.1 containing the E646Q ATPase
domain II mutant CSB (CSB-E646Q) (48)—were cultured
in Minimal Essential Medium plus 15% fetal bovine
serum, antibiotics and 400 mg/ml of geneticin (Invitrogen).
To investigate methyl methanesulfonate (MMS) and
5-hydroxymethyl-20-deoxyuridine (HmdU) sensitivity,
colony forming assays were performed essentially as
described (49). Briefly, 5 102 cells were plated onto a
60-mm dish, incubated for 16 h, and then treated with
different concentrations of MMS for 1 h. For HmdU
treatment, cells were plated in complete medium at a
density of 5 104 cells per 35-mm dish. After overnight
incubation, HmdU was added, and the cells were
incubated for an additional 24 h to permit incorporation.
After agent treatment, cells were re-plated in complete
media at a density of 1 102 per 60-mm dish. Colonies
were stained and counted after 10 days of growth.
RNA synthesis recovery
CSB-V and CSB-WT cells were grown in the presence of
[14C]thymidine (0.02 mCi/ml, Amersham or GE health-
care) for 3 days to label chromosomal DNA. Cells were
then washed with PBS prior to a 1 h treatment with 1mM
MMS. Fresh media was subsequently added to allow cells
to recover prior to measuring RNA synthesis at the
indicated times. To measure transcription, cells were
pulse-labeled with 5 mCi/ml [3H]uridine for 1 h at 378C,
washed twice with PBS, and lysed in 10mM Tris (pH 8.0),
150mM NaCl, 1mM EDTA buffer containing 0.5%
SDS and 100 mg/ml proteinase K for 1 h at 378C.
Trichloroacetic acid (TCA) (20%) was added to the cell
lysate and the samples were spotted onto glass fiber discs
(Whatman, Maidstone, UK). The filters were sequentially
washed in 5% TCA, 70% ethanol and acetone. The
TCA-precipitable radioactivity was scintillation-counted.
RESULTS
APE1 and CSB physically interact
Evidence suggests a role for CSB in facilitating global
genome, and possibly transcription-coupled BER (1). As a
means of elucidating the molecular involvement of CSB in
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BER, we examined for physical interactions of CSB with
proteins operating in this and related DNA repair
pathways. Specifically, initial studies employed a dot
blot technique, where select proteins were (i) spotted and
fixed to a capture membrane, (ii) incubated with purified
CSB in solution and (iii) probed for binding of CSB using
CSB-specific antibodies. Potential interactors identified
using this technique were the strand break sensor protein
PARP-1 (data not shown), the structure-specific endonu-
clease FEN1, the tyrosine kinase c-Abl and the major
human abasic endonuclease APE1 (Supplementary
Figure 1A: See online supplementary material for a
color version of this figure). No significant interaction
was seen with the tumor suppressor p53, the replication
processivity factor PCNA, the end-joining binding com-
plex Ku70/80, the Werner helicase, the protein defective in
Nijmegen Breakage Syndrome NBS1, the telomere repeat
binding protein TRF1, the recombination protein Rad51
and the single-stranded DNA binding protein RPA
(Supplemental Figure 1A and data not shown). Detailed
studies describing the interaction of CSB with PARP-1
have been reported elsewhere (35), and experiments with
other putative binding partners (e.g. c-Abl and FEN1) are
ongoing.
To interrogate the CSB–APE1 interaction further, we
performed both direct and indirect ELISAs. Direct
ELISAs, where APE1 was bound to the microtiter dish
surface, supported that CSB physically interacts with
APE1, as revealed by a concentration-dependent increase
in the CSB protein signal that is not observed with the
negative control protein BSA (Supplementary Figure 1B:
See online Supplementary Data for a color version of this
figure).Reciprocal experiments, however, where CSB was
fixed to the surface, did not reveal an interaction (data not
shown).
Thus, as an alternative method, an indirect ELISA
approach, where either an APE1- (Figure 1A) or CSB-
specific (Figure 1B) antibody was bound to the dish first
and then incubated with the appropriate purified protein,
was employed. In these studies, a reciprocal interaction
was observed (albeit weaker when using APE1 as the
binding probe; Figure 1B), and the increased signal in
both cases was generally unaffected by the presence of
ethidium bromide (EtBr) or DNase I (Figure 1A and B).
The APE1 and CSB antibodies also did not cross-react
non-specifically in the indirect ELISA experiments. These
findings indicate that the APE1–CSB binding is the
product of a direct, physical association and is indepen-
dent of DNA. Analysis of the indirect ELISA experiments
revealed an apparent binding affinity (i.e. the concentra-
tion at which approximately half maximal binding was
observed) for CSB and APE1 of 4.5 (when APE1 was
coated) to 20 nM (when CSB was coated).
APE1 and CSB are in a common complex within
human cell extracts
We next examined whether APE1 and CSB existed in a
common protein complex in human cell extracts using
immunoprecipitation techniques. CSB mutant human cells
(i.e. CS1AN.S3.G2) transfected with the pECFP–CSB
expression vector were employed [ECFP-CSB-CS1AN;
(8)], largely because antibodies directed against human
CSB worked inconsistently in our hands in immuno-
precipitation experiments. As shown in Figure 1C,
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Figure 1. CSB associates with APE1. Interaction between CSB and
APE1 in indirect ELISA. Mouse anti-APE1 (panel A) or anti-CSB
(panel B) was coated to the well. Purified APE1 (30 fmol, 1 ng) or CSB
(6 fmol, 1 ng) was then bound to the appropriate antibody. These
complexes were next incubated with different concentrations of CSB
(panel A) or APE1 (panel B) as indicated. Ethidium bromide (EtBr) or
DNase I was added where indicated. Values are means standard
errors (n=3). (C) CSB and Ape1 are in a common complex in human
cell extracts. Lysates from CS1AN cells transfected with the ECFP-CSB
plasmid were immunoprecipitated (IP) with either ECFP (left) or APE1
(right) antibodies. The IPs were then analyzed by immunoblotting (IB)
with either anti-CSB or anti-APE1 antibodies. Lysates of 10% of the
amount used for IP were loaded as input comparisons. As controls,
lysates IPed with rabbit IgG only were loaded (IgG Control), and IPs
with anti-ECFP were performed on extracts from ECFP-only expres-
sing cells (Vector Control).
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immunoprecipitation with antibodies specific for either
ECFP or APE1 pulled down both CSB and APE1
simultaneously from the ECFP-CSB-complemented
CS1AN extracts. In contrast, neither the IgG antibody
alone (negative control) nor the anti-ECFP antibody
used against extracts containing only the ECFP
fusion portion (vector control) precipitated either repair
protein (Figure 1C). Semi-quantitative densitometry
analysis of the western blot signals indicated that,
depending on the experiment, between roughly 5% and
50% of either APE1 or CSB was co-immunoprecipitated
with the other protein. The reason for the variability is
presently unknown, but may reflect differences in cell
culture conditions, cell cycle status or experimental
handling.
CSB stimulates APE1 endonuclease activity
As APE1 and CSB were found to physically interact and
co-immunoprecipitate from human cell extracts
(Supplementary Figure 1 and Figure 1), we next explored
whether this association had a functional effect on either
APE1 or CSB enzymatic activities. Using a 42F normal
(i.e. fully base-paired) duplex or a 42F 11-nt bubble
substrate [where F is an abasic site analog (50)], we
measured the effect of CSB on APE1 AP site incision
activity. As shown in Figure 2A, APE1 cleavage of normal
double-stranded AP–DNA was stimulated significantly in
a CSB concentration-dependent manner, with roughly
a 2-fold activation being observed at a molar ratio of
APE1 to CSB of 1 : 3, and a 4-fold activation being
detected at a 1 : 10 APE1 to CSB ratio. As expected,
CSB itself exhibited no AP endonuclease activity.
Moreover, no activation was observed with the CSB
storage buffer (Figure 2A), suggesting that the stimulation
was dependent on the CSB protein itself.
With the 11-nt AP site-containing bubble substrate,
which mimics a DNA transcription intermediate (44),
CSB protein was again found to stimulate APE1
endonuclease activity in a concentration-dependent
manner (Figure 2B). Significantly, CSB activation at
either an equal molar ratio (2-fold) or at a higher ratio
(up to 6-fold) was more profound with the bubble
substrate than with the fully paired AP duplex (up to
4-fold). This observation suggests some DNA specificity in
the activation, and is consistent with the higher affinity of
CSB for transcription bubble structures than for normal
double-stranded DNA (8)—an observation that supports
that the stimulatory effect on APE1 is CSB-dependent. As
above, CSB did not itself display AP endonuclease activity
on the bubble substrate. Notably, addition of ATP did not
affect the CSB stimulation of APE1 (Figure 2C). Last,
APE1 had no effect on CSB ATPase activity in the
presence of a 90-mer (35 nt)-bubble substrate (data not
shown) or the 42F(11)-bubble substrate (Supplementary
Figure 2: See online Supplementary Data for a color
version of this figure).
To determine whether the activation of APE1 was
indeed dependent on the CSB protein, we performed
incision assays using immunodepleted and immunopreci-
pitated CSB protein fractions (see Materials and Methods
section). As revealed by silver staining, immunodepletion
of CSB with anti-HA antibodies reduced CSB protein
levels in the recovered supernatant by 90% (data not
shown). Thus, as expected, and supportive of the
stimulation being CSB-dependent, the immunodepleted
supernatant (ID CSB) had a 10-fold reduced ability to
stimulate APE1 activity; that is, roughly equal stimulation
was observed at a 10-fold higher amount of the
immunodepleted CSB extract, relative to the purified
CSB protein or the immunoprecipitated (i.e. immunopuri-
fied, IP CSB) CSB protein (Figure 3A).
As another means of evaluating the specificity of the
CSB stimulation, we performed abasic site incision assays
with purified bacterial AP endonuclease IV. Endonuclease
IV is an E. coli protein with no sequence or structural
homology to the human APE1 protein, although both
enzymes exhibit many of the same biochemical repair
functions (51). As shown in Figure 3B, CSB had no effect
on endonuclease IV incision activity of the 11-nt bubble
substrate, even when present at a molar ratio of 100:1 (i.e.
at 10 fmol CSB); some inhibition was observed at the
higher molar ratios. This result indicates that the AP
endonuclease activation is specific to the human protein
combination (i.e. CSB and APE1). As an aside, the
findings here indicate that the ability to incise at AP sites
in transcription bubble configurations is a general
property of abasic endonucleases, both (unrelated) pro-
karyotic and eukaryotic.
We next examined whether CSB could stimulate the
endonuclease activity of a truncated APE1 protein lacking
the first 29 amino acid residues (i.e. 29APE1). As shown
in Figure 3C, purified CSB did not activate 29APE1
incision activity of the 11 nt AP site-containing 42-mer
bubble substrate, even at a molar ratio of 20 : 1. This result
indicates that CSB physically interacts with the unique,
unstructured N-terminal (REF-1) domain of APE1 (52)
and that the protein contact is critical for the observed
activation.
Employing a previously established electrophoretic
mobility shift assay, which omits the divalent cation
Mg2+ essential for APE1 catalysis (53), CSB was found
not to obviously promote APE1 binding to fully paired or
bubble-containing 42-mer AP–DNAs (Supplementary
Figure 3: See online Supplementary Data for a color
version of this figure). This finding argues that the
endonuclease stimulation is mediated through a direct
physical association with the APE1 protein (perhaps by
promoting a favorable conformational change in APE1
through the N-terminal interaction) and/or the introduc-
tion of a topological alteration in the DNA substrate that
permits a more efficient incision reaction. Interestingly,
APE1 induces a kink in DNA to facilitate both recogni-
tion and strand cleavage of AP sites (52). Finally, some
apparent binding of DNA was observed by CSB,
particularly at the higher protein concentrations
(Supplementary Figure 3).
The role of CSB in global genome AP site repair
As a means of evaluating the function of CSB in in vivo AP
site repair, we measured the steady-state level of abasic
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lesions in total chromosomal DNA isolated from both
CSB-V and CSB-WT fibroblasts using an established
aldehyde reactive probe method (54). These studies found
that both human cell lines maintain similar AP site levels
(Figure 4A). Consistent with this, both CSB-WT and
CSB-V whole cell extracts exhibited comparable total AP
site incision capacities on fully paired 34-mer duplex
substrates (Figure 4B and C). In addition, as with the
whole cell extracts, we did not detect any difference in
incision efficiency of normal duplex or bubble substrate
AP site-containing DNAs using nuclear extracts prepared
from CSB-WT or CSB-V cells (data not shown). These
results suggest that CSB does not obviously modulate
global genome repair of abasic lesions. However, the data
does not exclude a more specialized role for the CSB–
APE1 interaction in the repair of a subset of APE1
substrates, perhaps in regions of complex DNA structure.
Significantly, addition of recombinant CSB protein to
whole cell extracts prepared from CSB-V cells resulted in a
concentration-dependent stimulation of AP site incision
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efficiency (Figure 4D), supportive of the idea that
situations of high-localized concentrations of APE1 and
CSB may indeed foster AP site repair. We note that semi-
quantitative western blot analysis using CSB-WT whole
cell extracts indicated an overall ratio of APE1:CSB of
100:1 (data not shown).
CSB contributes toMMS andHmdU resistance
As an additional means of evaluating the cellular
contribution of CSB to the repair of BER substrates/
intermediates, we determined the sensitivity of the
SV40-transformed CSB mutant fibroblast cell line
CS1AN.S3.G2 complemented with either a control
vector (CSB-V) or a recombinant plasmid express-
ing wild-type human CSB (CSB-WT) (48) to the mono-
functional alkylating agent MMS and the thymidine
analog HmdU. For MMS, the most critical biological
lesion is presumed to be the N-methylation base products,
which frequently give rise to AP sites via enhanced
hydrolysis of the N-glycosylic bond or DNA glycosylase-
mediated base release (55). HmdU is an oxidative base
product formed by attack of intracellular ROS as well as
by way of deamination of HmdC, another oxidative base
lesion. Repair of HmdU in chromosomal DNA proceeds
through a SMUG1-initiated BER response (56). Prior
studies have established that exposure to exogenous
HmdU in the culture medium induces cell killing in a
manner that is dependent on the formation of BER
intermediates in DNA, and not the base itself (57). As
shown in Figure 5, CSB-V cells exhibit an 3-fold increase
in sensitivity to both MMS (panel A, 0.48mM) and
HmdU (panel B, 5.4mM), as determined by the LD37
doses relative to the CSB-WT control (MMS, 1.3mM;
HmdU, 17.1 mM). These findings provide novel evidence
for a direct role of CSB in the repair of BER substrates/
intermediates, possibly AP sites or single-strand breaks
(SSBs), which are common to the two agents. As seen
previously (48), we did not detect an increased sensitivity
of the CSB-V cells (studied here) to hydrogen peroxide
(data not shown).
As ATP was not critical to the APE1 activation
(Figure 2C), we determined the contribution of the
ATPase function of CSB to MMS resistance. Our studies
reveal that CSB-deficient CS1AN cells expressing an
ATPase domain II mutant CSB protein (i.e. CSB-
E646Q) display intermediate sensitivity to MMS chal-
lenges (Figure 5A). This finding indicates both a structural
and an enzymatic role for CSB in the MMS response.
DISCUSSION
We report herein that CSB and the major human AP
endonuclease, APE1, directly interact, as well as exist in a
common protein complex in human cells (Supplementary
Figure 1 and Figure 1). As seen upon UV exposure (58),
the composition of the CSB protein complex likely
changes depending on the cellular environment, perhaps
explaining the variability seen in the co-IP studies reported
within (see Results section). Investigations to further
analyze the nature of the CSB complex during different
cell cycle stages or upon challenges with disparate DNA-
damaging agents (e.g. oxidizing or alkylating compounds)
are warranted. We also found that CSB stimulates APE1
AP site incision activity on abasic site-containing DNA
substrates—in an ATP-independent, species-specific
manner (no activation of E. coli endonuclease IV was
observed by CSB)—likely via a direct interaction with the
N-terminal ‘REF-1 region’ of APE1. This stimulation was
more pronounced on a transcription-mimic bubble
structure in comparison with a fully base-paired, ‘classical’
abasic site BER substrate (Figure 2). For instance, we
detected a 2-fold enhanced incision activity of APE1 on
the bubble duplex at a 1 : 1 CSB:APE1 molar ratio [keep
in mind that CSB likely operates as a functional dimer
(59)], whereas no stimulation was observed at this ratio on
the fully paired double-stranded AP-DNA. Thus, in
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addition to coordination with DNA glycosylases in
endogenous base damage repair and PARP-1 in DNA
damage responses (see Introduction section), the interac-
tion with APE1 suggests a more general function of CSB
in modulating BER processes.
Despite the strong biochemical stimulation noted
above, we found no clear evidence for a role of CSB in
the global genome repair of endogenous, natural (hydro-
lytic) abasic sites (Figure 4). However, in light of the more
pronounced activation seen with the bubble substrate,
we favor a model whereby the CSB–APE1 interaction is
most critical to regions of the genome where complex
DNA structures are formed, such as during transcription
or replication, or at sites of recombination (R-DNA or
telomeres), where the local, relative concentrations of
these proteins may also be higher. Moreover, a more
specialized role for this interaction in the repair of a
specific subset of APE1-targeted damages could exist.
For instance, CSB may promote excision of oxidized
AP sites or certain base modifications (e.g. 5,6-dihydro-
20-deoxyuridine, 5,6-dihydrothymidine, 5-hydroxy-20-
deoxyuridine, a-20-deoxyadenosine and a-thymidine
adducts), which have all been shown to be substrates for
APE1 repair activity (60,61). We note that we did not see
any obvious activation of the APE1 30 to 50 exonuclease
activity on a 30-recessed primer-template DNA duplex
(unpublished data), supporting a specificity to the
CSB–APE1 interaction.
While the idea of TCR of BER substrates is
controversial, it is possible that CSB facilitates APE1
repair within actively transcribed genes. Interestingly,
our preliminary data indicate a delayed RNA synthesis
recovery in CSB mutant cells following MMS exposure
(Supplementary Figure 4: See online Supplementary Data
for a color version of this figure), suggesting that certain
BER substrates/intermediates may indeed be handled in a
gene-specific or potentially TCR-specific manner. Prior
reports in fact indicate that hydrolytic or oxidized abasic
lesions create a pause or arrest site for elongating RNA
polymerases (62–68), and a stalled RNA polymerase is
critical for the initiation of TCR and the recruitment of
CSB (20,69). SSBs are also blocks to RNA polymerase
progression (70), whereas alkylation base damage does
not appear to be corrected in a TCR mechanism (71).
Innovative methodologies to accurately and specifically
evaluate genome (region)-specific repair and TCR of BER
lesions are needed.
To our knowledge, we provide the first evidence
that CSB mutant cells are defective in the repair of
MMS-induced DNA damage, as well as DNA products
generated after HmdU incorporation. Since both of these
agents induce cell killing through the production of BER
substrates/intermediates, the colony survival assays herein
(Figure 5) provide compelling evidence that CSB mutant
cells are defective in the efficient or productive removal of
cytotoxic BER products, likely AP sites and/or DNA
SSBs, which are common to these two agents. Consistent
with this interpretation, prior studies have documented a
clear and reproducible hypersensitivity of cells defective in
a central BER participant to MMS and HmdU challenges.
In particular, APE1, POLb, XRCC1 and PARP1 mutant
cells exhibit extreme sensitivity to both MMS (72–76) and
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HmdU [(77–79) and unpublished data]. Thus, combined
with the reduced base damage removal and the increased
sensitivity to oxidizing agents displayed by CSB mutant
cells (see Introduction section), evidence is mounting that
supports a role for CSB in facilitating a BER-related
response.
The lack of an effect of ATP on the CSB-dependent
activation of APE1, and the observation that the ATPase
mutant protein (E646Q) only partially corrects the MMS
sensitivity of CSB mutant cells (Figure 5A), suggests that
this SNF2/SWI2 family member can function in BER in a
chromatin remodeling-independent manner. This conclu-
sion is in line with previous findings that uncovered
normal hydrogen peroxide and g irradiation sensitivity, as
well as 8-oxo-dG incision activity, for CS1AN.S3.G2 cells
transfected with the E646Q mutant (26,48). These results
imply that CSB modulates BER primarily through protein
complex associations (direct or indirect), or via a more
subtle (ATP-independent) modification of the DNA
structure. Notably, a functional ATPase activity, while
necessary for chromatin remodeling, is not required for
the induction of topological change in naked DNA (6).
Thus, a story is emerging that suggests a distinct role for
CSB in facilitating BER in comparison with NER, where
the ATPase function of the protein (and energy) is more
critical to the repair of UV-induced DNA damage (13,48).
With that said, the partial complementation of E646Q
(Figure 5A) does indicate a role for the ATPase function
(and presumably the remodeling activity) of CSB in the
MMS response as well. Further studies to more thor-
oughly define the precise biochemical contributions of
CSB to the different DNA damage-response pathways (i.e.
the contribution of protein–protein interactions, the ATP-
dependent remodeling activity, or the ability to manip-
ulate naked DNA) are a priority.
In summary, we report a physical and functional
interaction between CSB and APE1, where the CSB-
dependent stimulatory effect on APE1 incision activity,
particularly on a bubble structure, is quite pronounced
relative to other APE1 interactions (80). Moreover, we
demonstrate that CSB mutant cells exhibit a profound
hypersensitivity to DNA-damaging agents that create
BER-type substrates/intermediates, namely MMS and
HmdU, and display an impaired RNA synthesis recovery
following MMS exposure. These findings provide further
evidence for a role of CSB in the processing of BER-
specific DNA substrates, potentially in regions of the
genome that take on complex structures.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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